| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Breast Neoplasms; Triple Negative Breast Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Obesity | Phase 4 | ClinicalTrials |
| Anemia, Sickle Cell | Phase 1 | ClinicalTrials |
| Insulin Resistance | Phase 1 | ClinicalTrials |
| Hypercapnia; Hypoxia | Phase 1 | ClinicalTrials |
| Sarcopenia | Phase 1 | ClinicalTrials |
| Diabetes Mellitus, Type 2 | Phase 4 | ClinicalTrials |
| Anemia, Sickle Cell | Phase 1 | ClinicalTrials |
| Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; DNA Repair-Deficiency Disorders; Hodgkin Disease; Lung Neoplasms; Lymphoma; Melanoma; Squamous Cell Carcinoma of Head and Neck; Urinary Bladder Neoplasms | Phase 1 | ClinicalTrials |
| Hypertension; Obesity | Phase 1 | ClinicalTrials |
| Anemia, Sickle Cell | Phase 2 | ClinicalTrials |
| Endotoxemia | Phase 1 | ClinicalTrials |
| Hypertension; Hypertension, Pulmonary | Phase 1 | ClinicalTrials |
| Anemia, Sickle Cell | Phase 2 | ClinicalTrials |
CONTENTS